ARMATA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)

Item 7.01. Regulation FD Disclosure.

Included as Exhibit 99.1 to this Current Report on Form 8-K is a copy of a corporate presentation that Armata Pharmaceuticals, Inc. (the "Company") shared in connection with the LifeSci Partners 11th Annual Corporate Access Event on January 5, 2022.

The information contained in this Item 7.01 and the attached Exhibit 99.1 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 7.01 and the attached Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

 Item 8.01. Other Events.

On January 5, 2022, the Company issued a press release providing an update on Pseudomonas respiratory programs. The press release is attached as Exhibit 99.2 to this Current Report on Form 8-K.

 Item 9.01.   Financial Statements and Exhibits.




(d) Exhibits.



Exhibit  Description
Number
  99.1     Corporate Presentation.
  99.2     Press Release.
104      Cover Page Interactive Data File (embedded within Inline XBRL document).

© Edgar Online, source Glimpses